For the Inventor, By the Inventor

Enter assignee name

Mountain View, CA, United States of America

Bioelectron Technology Corporation

Calculating rank

USPTO Granted Patents = 13

% Expired Patents = 53.8

CIPO Patents = 16

EPO Patents = 11

Forward Citations = 27

Loading Chart...

Loading Chart...

16 inventors (with patents filed for the assignee):

Andrew W Hinman (5 out of 22 patents)

Paul Mollard (5 out of 26 patents)

Kieron E Wesson (4 out of 26 patents)

4. Guy M Miller (4 out of 22 patents)

5. William Dvorak Shrader (4 out of 22 patents)

6. Orion D Jankowski (3 out of 20 patents)

7. Viktoria Kheifets (2 out of 16 patents)

8. Christopher R Cornell (2 out of 4 patents)

9. Dana Davis (2 out of 4 patents)

10. Peter Giannousis (1 out of 7 patents)

11. Shazad Suchit (1 out of 4 patents)

12. Mahmoud Mirmehrabi (1 out of 17 patents)

13. Sidney M Hecht (1 out of 57 patents)

14. Kieron W Wesson (1 out of 1 patent)

15. Guy M Miller (0 patent)

13 patents: Sort by Forward Citations

1. 10251847 - Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide (2019-04-09),

2. 10202325 - Methods for selective oxidation of alpha tocotrienol in the presence of non-alpha tocotrienols (2019-02-12),

3. 10195161 - Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones (2019-02-05),

4. 10189830 - Alkyl-heteroaryl substituted quinone derivatives for treatment of oxidative stress disorders (2019-01-29),

5. 10167251 - 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases (2019-01-01),

6. 10105325 - Treatment of pervasive developmental disorders with redox-active therapeutics (2018-10-23),

7. 10071978 - Process for the production of alpha-tocotrienol and derivatives (2018-09-11),

8. 10039722 - Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions in the function of red cells (2018-08-07),

9. 10029971 - Methods for selective oxidation of alpha tocotrienol in the presence of non-alpha tocotrienols (2018-07-24),

10. 9932286 - Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers (2018-04-03),

11. 9868711 - Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders (2018-01-16),

12. 9670170 - Resorufin derivatives for treatment of oxidative stress disorders (2017-06-06),

13. 9629815 - Benzoquinone derivatives for treating oxidative stress disorders (2017-04-25),

Company Overview

Bioelectron Technology Corporation is a pioneering organization based in Mountain View, California, specializing in the development of innovative bioelectronic devices. The company focuses on harnessing the power of bioelectronics to create solutions that enhance health and well-being. Their research spans various domains, including medical devices and therapeutic technologies, aiming to bridge the gap between biology and electronics. Through advanced engineering and scientific expertise, Bioelectron is committed to transforming healthcare and improving patient outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

13 Patents

#204 in Mountain View, CA

#5,674 in California

#23,898 in US

#45,181 in the World

Mountain View, CA, United States of America

Bioelectron Technology Corporation

Forward Citations = 27

16 inventors:

Andrew W Hinman (5 out of 22 patents)

Paul Mollard (5 out of 26 patents)

Kieron E Wesson (4 out of 26 patents)

4. Guy M Miller (4 out of 22 patents)

5. William Dvorak Shrader (4 out of 22 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bioelectron Technology Corporation. Retrieved from https://idiyas.com/company/bioelectron-technology

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…